• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发一种自动化的酶法来定量测定红细胞中的丙酮酸激酶。

Development of an Automated Enzymatic Method to Quantify Pyruvate Kinase in Red Blood Cells.

机构信息

ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT.

出版信息

J Appl Lab Med. 2020 Jan 1;5(1):54-61. doi: 10.1373/jalm.2019.029579.

DOI:10.1373/jalm.2019.029579
PMID:32445340
Abstract

BACKGROUND

Pyruvate kinase (PK) deficiency is the most common cause of nonspherocytic hemolytic anemia owing to defective glycolysis. This study developed and validated an automated method to measure PK activity in red blood cells (RBCs).

METHODS

PK catalyzes the reaction of phosphoenolpyruvate with ADP to form pyruvate and ATP. The pyruvate is reduced in the presence of lactate dehydrogenase and NADH to produce lactate and NAD+. The rate of absorbance decrease at 340 nm is proportional to PK activity. PK and hemoglobin (Hb) measurements were performed on a Roche cobas c501 analyzer. After establishing a k-factor, accuracy, linearity, imprecision, sensitivity, and stability were validated and the reference interval was verified.

RESULTS

The k-factor was -9477. Accuracy was evaluated by method comparison (n = 56). Linear regression yielded y = 1.0x - 0.57, and R2 of 0.93. Linearity was determined by combining a high sample with hemolyzing solution in 6 different ratios. Linear regression analysis yielded y = 1.02x - 2.68, and R2 of 1.0. The assay was linear to 87 U/dL. Precision was evaluated by testing hemolysates in 3 replicates/day for 10 days. Within-run imprecision was 1.9% and 2.5% and total imprecision was 4.0% and 5.6% at 14.0 and 8.1 U/g Hb, respectively. The limit of blank was 0.0, and the limit of detection was 1.0 U/dL. Stability was determined in 4 sample types at 3 different temperatures; the changes were all <10% when compared with t0. The current PK reference interval of 4.6 to 11.2 U/g Hb was verified.

CONCLUSIONS

This automated assay for quantifying PK in RBCs has acceptable performance characteristics and is fit for intended use.

摘要

背景

丙酮酸激酶(PK)缺乏是由于糖酵解缺陷导致非球形红细胞溶血性贫血的最常见原因。本研究开发并验证了一种自动测定红细胞(RBC)中 PK 活性的方法。

方法

PK 催化磷酸烯醇丙酮酸与 ADP 的反应,形成丙酮酸和 ATP。在存在乳酸脱氢酶和 NADH 的情况下,丙酮酸被还原为乳酸和 NAD+。340nm 处吸光度的下降速率与 PK 活性成正比。PK 和血红蛋白(Hb)的测量在罗氏 cobas c501 分析仪上进行。建立 k 因子后,验证了准确性、线性、精密度、灵敏度和稳定性,并验证了参考区间。

结果

k 因子为-9477。通过方法比较(n=56)评估准确性。线性回归得到 y=1.0x-0.57,R2 为 0.93。通过将高浓度样本与溶血溶液以 6 种不同比例混合来确定线性范围。线性回归分析得到 y=1.02x-2.68,R2 为 1.0。该测定法的线性范围为 87U/dL。通过每天在 3 个复孔中测试溶血物,连续 10 天评估精密度。批内精密度分别为 1.9%和 2.5%,总精密度分别为 4.0%和 5.6%,Hb 为 14.0 和 8.1U/g。空白限为 0.0,检测限为 1.0U/dL。在 4 种样本类型和 3 种不同温度下确定稳定性;与 t0 相比,所有变化均<10%。当前的 PK 参考区间为 4.6 至 11.2U/g Hb,得到验证。

结论

这种自动测定 RBC 中 PK 的方法具有可接受的性能特征,适合预期用途。

相似文献

1
Development of an Automated Enzymatic Method to Quantify Pyruvate Kinase in Red Blood Cells.开发一种自动化的酶法来定量测定红细胞中的丙酮酸激酶。
J Appl Lab Med. 2020 Jan 1;5(1):54-61. doi: 10.1373/jalm.2019.029579.
2
[How I do in front of an hemolytic anemia of unknown etiology?].面对病因不明的溶血性贫血我该怎么做?
Ann Biol Clin (Paris). 2018 Oct 1;76(5):493-503. doi: 10.1684/abc.2018.1381.
3
The pyruvate kinase (PK) to hexokinase enzyme activity ratio and erythrocyte PK protein level in the diagnosis and phenotype of PK deficiency.丙酮酸激酶(PK)与己糖激酶酶活性比值和红细胞 PK 蛋白水平在 PK 缺乏症的诊断和表型中的应用。
Br J Haematol. 2021 Mar;192(6):1092-1096. doi: 10.1111/bjh.16724. Epub 2020 May 28.
4
Cord blood transplantation in a young child with pyruvate kinase deficiency.丙酮酸激酶缺乏症幼儿的脐血移植
Pediatr Int. 2016 Jul;58(7):634-6. doi: 10.1111/ped.12889. Epub 2016 Mar 8.
5
Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency.解决丙酮酸激酶缺乏症的诊断差距:丙酮酸激酶缺乏症诊断的共识建议。
Am J Hematol. 2019 Jan;94(1):149-161. doi: 10.1002/ajh.25325. Epub 2018 Nov 28.
6
Mitral Valve Replacement With Cardiopulmonary Bypass in a Patient With Pyruvate Kinase Deficiency.一名丙酮酸激酶缺乏症患者在体外循环下进行二尖瓣置换术。
J Cardiothorac Vasc Anesth. 2017 Feb;31(1):262-265. doi: 10.1053/j.jvca.2016.03.146. Epub 2016 Mar 23.
7
Chronic haemolytic anaemia because of pyruvate kinase (PK) deficiency in a child heterozygous for haemoglobin S and no clinical features of sickle cell disease.一名血红蛋白S杂合子儿童因丙酮酸激酶(PK)缺乏导致慢性溶血性贫血,且无镰状细胞病的临床特征。
Eur J Haematol. 2010 Jan 1;84(1):89-90. doi: 10.1111/j.1600-0609.2009.01353.x. Epub 2009 Sep 16.
8
Laboratory approach to investigation of anemia with a focus on pyruvate kinase deficiency.实验室检查贫血的方法——以丙酮酸激酶缺乏症为例。
Int J Lab Hematol. 2020 Jun;42 Suppl 1:107-112. doi: 10.1111/ijlh.13200.
9
Screening of hereditary spherocytosis and pyruvate kinase deficiency by automated blood count using erythrocytic and reticulocytic parameters.应用红细胞和网织红细胞参数的自动化血细胞计数筛选遗传性球形红细胞增多症和丙酮酸激酶缺乏症。
Int J Lab Hematol. 2018 Dec;40(6):697-703. doi: 10.1111/ijlh.12906. Epub 2018 Sep 5.
10
Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency.米他培坦治疗丙酮酸激酶缺乏症的安全性和疗效。
N Engl J Med. 2019 Sep 5;381(10):933-944. doi: 10.1056/NEJMoa1902678.

引用本文的文献

1
Case report: Compound heterozygosity in gene with a large exon deletion and a novel rare p.Gly536Asp variant as a cause of severe pyruvate kinase deficiency.病例报告:基因中的复合杂合性,伴有一个大的外显子缺失和一个新的罕见的p.Gly536Asp变体,为严重丙酮酸激酶缺乏症的病因。
Front Pediatr. 2022 Dec 1;10:1022980. doi: 10.3389/fped.2022.1022980. eCollection 2022.